CD44 is expressed in hepatocellular carcinomas showing vascular invasion

Journal of Pathology

Volumn 179, Issue 1, 1996, Pages 74-79

  Mathew, Joseph ^a   Mines, Julie E ^a   Obafunwa, John O ^b   Burr, Andrew W ^a   Toole, Kieran ^a   Burt, Alastair D ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b George Town Hospital Cayman   (Cayman Islands)

Author keywords

CD44; Cell adhesion molecules; Hepatocellular carcinoma; Tumour grade; Tumour proliferation indices; Vascular invasion

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN;

ARTICLE; CANCER INVASION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, CD44; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; PROGNOSIS; UP-REGULATION; VASCULAR NEOPLASMS;

EID: 0029895551     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199605)179:1<74::AID-PATH531>3.0.CO;2-E     Document Type: Article

References (25)

1. Albelda SM, Buck CA. Integrins and other cell adhesion molecules FASEB J 1990; 4: 2868-2880
2. Albelda SM, Biology of disease. Role of integrins and other cell adhesion molecules in tumour progression and metastasis (Review). Lab Invest 1993; 68: 4-17.
3. Haynes BF, Liao H-X, Patton KL The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms Cancer Cells 1991; 3: 347-350.
4. Underbill C. CD44 the hyaluron receptor. J Cell Sci 1992, 103: 293-298
5. Koopman G, Griffioen AW, Ponta H, et al. CD44 splice variants, expression on lymphocytes and in neoplasia. Res Immunol 1993; 144: 750-754.
6. Mackay CR, Terpe H-J, Stauder R, Maiston WL, Stark H. Günthert U. Expression and modulation of CD44 variant isoforms in humans J Cell Biol 1994; 124: 71-82
7. Fox SB, Fawcett J, Jackson DG, et al Normal human tissues, in addition to some tumours, express multiple different CD44 isoforms. Cancer Res 1994; 54: 4539-4546
8. Miyake K, Underbill CB, Lesley J, Kincade PW Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990, 172: 69-75
9. Ishii S, Ford R, Thomas P, Nachman A, Steele G Jr, Jessup JM. CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen. Surg Oncol 1993, 2: 255-264
10. Matsumara Y, Tarin D Significance of CD44 gene products for cancer diagnosis and disease evaluation Lancet 1992; 340: 1053-1058.
11. Tarin D, Matsumara Y Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy J Cell Biochem 1993; 17G(Suppl); 173-185
12. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24
13. Rudy W, Hofmann M, Schwartz-Albeiz R, et al Two major CD44 proteins expressed on a metastatic rat tumour cell line are derived from different splice variants; each one individually suffices to confer metastatic behaviour Cancer Res 1993; 53: 1262-1268.
14. Reber S, Matzku S, Günthert H, Ponta P, Herrlich P, Zoller M. Retardation of metastatic tumour growth after immunisation with metastasis-specific monoclonal antibodies. Int J Cancer 1990; 46: 919-927.
15. Seiter S, Arch R, Reber S, et al. Prevention of tumour metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443-455
16. Heider K-H, Hofman M, Horst E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps J Cell Biol 1993; 120: 227-233.
17. Koopman G, Heider K-H, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkins lymphomas express a homologue of the rat metastasis-associated variant of CD44 J Exp Med 1993; 177: 897-904.
18. Tanabe KK, Ellis LM, Saya H Expression of CD44R1 adhesion molecule in colon carcinomas and metastasis. Lancet 1993; 341: 725-726
19. Weilanga VJM, Heider K-H, Offerhaus JA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumour progression Cancer Res 1993; 53: 4754-4756.
20. Grigioni WF, Garbisa S, D'Errico A, et al. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens Am J Pathol 1991, 138: 647-654
21. Torii A, Harada A, Nakao A, Nonami T, Ito M, Takagi H Expression of intracellular adhesion molecule-1 in hepatocellular carcinoma. J Surg Oncol 1993, 53: 239-242
22. Carlo P, Roncalli M, Gambacorta M, Cominotti M, Coggi G, Viale G. The patterns of integrin. common β1 and collagen IV immunoreactivity in hepatocellular carcinoma Correlations with tumour growth rate, grade and size. J Pathol 1993; 171: 5-11.
23. Craig JR, Peters RL, Edmondson HA. Primary malignant epithelial tumours. In: Hartmann WH, Sobin LH, eds Tumours of the Liver and Intrahepatic Bile Ducts. Atlas of Tumour Pathology. Vol 26, 2nd Series. Washington DC: Armed Forces Institute of Pathology, 1989; 123-222
24. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIBI. Histopathology 1993, 22: 355-360.
25. Dalchau R, Flanagan BF, Allen AK, Daar AS, Fabre JW Chemical composition and tissue distribution of the human CD44 glycoprotein In: Knapp W, Dörken B, Gilks WR, et al. eds Leucocyte Typing IV. Oxford. Oxford University Press, 1989; 622-625.